Health Economic Evaluation of an Adapted Physical Activity Program for Women With Breast Cancer

Condition(s) studied

Investigational drug(s) / intervention(s)

APA Program: Patients treated and monitored for their breast cancer following the 6-month APA program.

Recommendations for physical activity: Patients treated and monitored for their breast cancer who have received recommendations for physical activity as well as a 6-month activity schedule. To facilitate patient acceptance and participation in this study, patients who will be randomized to the control group will be offered to follow the APA program after one year of inclusion

Study summary

Adapted physical activity (APA) was recognized as a non-drug therapy by the French Health Authority (HAS) in 2011. Very few studies have examined the efficiency of APA programs during the active phase of treatment in cancer patients. The investigators assumed that non-drug therapy such as APA could improve the quality of life and reduces health costs. The main objective of this study is to assess the efficiency of a standardized APA program, as compared to conventional management including simple recommendations for the practice of physical activity in women in phase active breast cancer treatment.

Eligibility

Primary outcome measure(s)

• Comparison of physical activity programmes — 12 months
  Evaluation of the differential cost-utility ratio (cost / QALY), according to the perspective of the community over a 12-month period, of an adapted physical activity program (APA) in comparison to conventional care, including simple recommendations for physical activity for patients with breast cancer during the active phase of treatment.

Trial sites (1)

More University Hospital, Toulouse trials in France

Other trials for the same condition